GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

41

Inflammation Creates New Therapeutic Vulnerabilities in Cancer: Nature Genetics | June 2026

Cancer cells constantly adapt to inflammatory stress generated by the immune system, particularly during immune checkpoint inhibitor therapy. This study explored whether inflammatory cytokines such as interferon-γ (IFNγ),...

42

TLS Atlas: Turning Tumor Immune Architecture into a Clinical Biomarker: Science | May 2026

Tertiary lymphoid structures are local immune hubs within tumors, but this study shows that their mere presence is not enough; their maturation, location, and cellular organization determine biological...

43

CLDN18.2 in PDAC: KRAS and Hyperglycaemia Create a Resistance Mechanism: Gut | 2026

CLDN18.2 is emerging as a therapeutic target in gastrointestinal cancers, but its benefit in pancreatic ductal adenocarcinoma has been limited. This study identifies a key resistance mechanism: KRAS...

44

The Oral–X Axis: How Oral Dysbiosis Drives Systemic Disease: Genes & Diseases | June 2026

The oral cavity contains the second largest microbial ecosystem in the human body and acts as a major interface between the external environment and multiple organ systems. This...

45

Exercise After Bariatric Surgery: Gut Microbiota as a Metabolic Amplifier: International Journal of Obesity | June 2026

This translational study investigated whether exercise-induced changes in gut microbiota contribute to the metabolic benefits observed after Roux-en-Y gastric bypass surgery. Thirty-two women undergoing bariatric surgery were randomized...

46

Bacterial Signaling Molecules Drive Colitis-Associated Cancer : Gastroenterology | Jun 2026

Introduction: Chronic inflammation is the principal driver of colitis-associated cancer (CAC) in patients with long-standing ulcerative colitis (UC). Although the intestinal microbiome has long been implicated in colorectal...

47

KRAS–O-GlcNAc Axis Drives CLDN18.2 Resistance in PDAC : Gut | June 2026

Introduction: Introduction: Claudin 18.2 (CLDN18.2) has emerged as an important therapeutic target in gastrointestinal malignancies, with encouraging results in gastric and gastroesophageal cancers. Its expression in pancreatic ductal...

48

APE1–SOX9 Axis Drives Chemoresistance in Esophageal Cancer : Gastroenterology | June 2026

Introduction: Esophageal Adenocarcinoma is an aggressive malignancy strongly associated with chronic gastroesophageal reflux disease and exposure to acidic bile reflux. Despite advances in multimodal therapy, chemotherapy resistance remains...

49

Single-Dose PCSK9 Base Editing Achieves Durable LDL Reduction : NEJM | May 2026

Introduction Hypercholesterolemia remains a major driver of atherosclerotic cardiovascular disease despite the availability of statins, PCSK9 inhibitors and RNA-based therapies. Lifelong treatment adherence and incomplete LDL reduction continue...

50

Pediatric Single-Cell Liver Atlas Reveals Distinct Age-Dependent Immune and Fibrotic Signatures : Hepatol Commun | May 2026

Introduction Liver development during childhood involves dynamic metabolic, immune and stromal maturation processes that differ substantially from adult liver biology. However, most hepatic single-cell reference atlases and mechanistic...

Previous
145615
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer